News

Stay informed with expert insights, case studies, and tools to help your lab improve performance and make smarter revenue decisions.

Patent Eligibility Restoration Act Could Lead to Increased Costs for Critical Genetic Testing

Patent Eligibility Restoration Act Could Lead to Increased Costs for Critical Genetic Testing

Read More

CMS Ends Enforcement Discretion for Remote Review of Cytology Digital Slides

The U.S. Centers for Medicare & Medicaid Services (CMS) revised the Clinical Laboratory Improvement Amendments of 1988...

Read More

TELCOR Promotions - October 2025

TELCOR is proud to announce the promotion of Chad Erickson, Development Manager, RCM; Ami Johnson, Senior Compliance...

Read More

Medical Organizations Send Letter to CMS to Advocate for Expanded MIPS Quality Measures

Several medical organizations, including the College of American Pathologists and the American Medical Association,...

Read More

House Subcommittee Hearing Discusses Legislation Related to Medical Screening Tests and Services Access

The U.S. House of Representatives Committee on Energy and Commerce held a hearing Thursday to discuss legislation...

Read More

Bipartisan RESULTS Act Introduced to Protect Access to Laboratory Services

The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (H.R. 5269/S.2761) was...

Read More

CAP Calls for Improvements to Health Information Technology at HHS

The College of American Pathologists (CAP) is urging the U.S. Department of Health and Human Services (HHS) to make...

Read More

TELCOR Promotions - September 2025

TELCOR is proud to announce the promotion Amber Manry to Claim Resolution Lead, Revenue Cycle Services, Daniela Miller...

Read More

CAP Advocates for Tariff Exemption for Medical Device Products, Including Laboratory Supplies

The College of American Pathologists (CAP) is urging the U.S. Department of Commerce to exempt medical device products,...

Read More

TELCOR POC Device Connectivity Updates - Q2 2025

Lincoln, NE – August 19, 2025

Read More

FDA Formally Rescinds Laboratory-Developed Tests Final Rule

The U.S. Food and Drug Administration (FDA) formally rescinded its final rule regulating laboratory-developed tests as...

Read More